Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 4, 2007, Pages 760-769

  Halwani, Majed ^a   Mugabe, Clement ^a   Azghani, Ali O ^b   Lafrenie, Robert M ^c   Kumar, Aseem ^a   Omri, Abdelwahab ^a  

^a LAURENTIAN UNIVERSITY   (Canada)

^b UNIVERSITY OF TEXAS AT TYLER   (United States)

^c Northeastern Ontario Regional Cancer Centre   (Canada)

Author keywords

B. cenocepacia; Bacteria; Fusion; Liposomes; Stability

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CHOLESTEROL; GENTAMICIN; LIPOSOME; PHOSPHATIDYLCHOLINE; TOBRAMYCIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BILAYER MEMBRANE; BURKHOLDERIA CENOCEPACIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG STABILITY; ENCAPSULATION; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LUNG LAVAGE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMA; RAT; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; CELL MEMBRANE; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; COLONY COUNT, MICROBIAL; DRUG STABILITY; FLOW CYTOMETRY; HUMANS; IMMUNOCHEMISTRY; LIPIDS; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHATIDYLCHOLINES; TEMPERATURE;

EID: 34548758436     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm289     Document Type: Article

References (38)

1. Heijerman H. Infection and inflammation in cystic fibrosis: A short review. J Cyst Fibros 2005; 4: 3-5.
2. Chu KK, Davidson DJ, Halsey TK et al. Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect Immun 2002; 70: 2715-20.
3. Coenye T, Vandamme P, Govan JR et al. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin Microbiol 2001; 39: 3427-36.
4. Cunha MV, Sousa SA, Leitao JH et al. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol 2004; 42: 3052-8.
5. Rajyaguru JM, Muszynski MJ. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds. J Antimicrob Chemother 1997; 40: 345-51.
6. Vyas SP, Quraishi S, Gupta S et al. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int J Pharm 2005; 296: 12-25.
7. Anwer K, Kao G, Rolland A et al. Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells. J Drug Target 2004; 12: 215-21.
8. Chaltin P, Margineanu A, Marchand D et al. Delivery of anti-sense oligonucleotides using cholesterol-modified sense dendrimers and cationic lipids. Bioconjug Chem 2005;.16: 827-36.
9. Hass PR, Boczkowski D, Nair SK et al. Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Cancer Immunol Immunother 2006; 55: 672-83.
10. Bekersky I, Boswell GW, Hiles R et al. Safety toxicokinetics tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): A 91-day study in rats. Pharm Res 2000; 17: 1494-502.
11. Sachetelli S, Khalil H, Chen T et al. Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. Biochim Biophys Acta 2000; 1463: 254-66.
12. Schiffelers R, Storm G, Bakker-Woudenberg I. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother 2001; 48: 333-44.
13. Henry DA, Mahenthiralingam E, Vandamme P et al. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol 2001; 39: 1073-8.
14. Miller RA, Walker RD, Carson J et al. Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria. Dis Aquat Organ 2005; 64: 211-22.
15. Mugabe C, Azghani AO, Omri A Preparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibiotics. Int J Pharm 2006; 307: 244-50.
16. Kirby CJ, Gregoriadis G. Dehydration-rehydration vesicles: A simple method for high yield drug entrapment in liposomes. Biotechnology 1984; 2: 979-84.
17. Mugabe C, Azghani AO, Omri A. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 2005: 55: 269-71.
18. Nathens AB, Marshall JC, Watson RW et al. Diethylmaleate attenuates endotoxin-induced lung injury Surgery 1996; 120: 360-6.
19. Rukholm G, Mugabe C, Azghani AO et al. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: A time-kill study. Int J Antimicrob Agents 2006; 27 47-52.
20. Struck DK, Hookstra, D, Pagano RE. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 1981; 20: 4093-9.
21. Bendayan M. Colloidal gold post-embedding immunocytochemistry. Prog Histochem Cytochem 1995; 29: 1-159.
22. Shah SP, Misra A. Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance AAPS PharmSciTech 2004; 5: E65.
23. Antos M, Trafny EA, Grzybowski O. Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro. Pharmacol Res 1995; 32: 85-7.
24. Chong PL, Choate D. Calorimetric studies of the effects of cholesterol on the phase transition of C(18):C(10) phosphatidylcholine. Biophys J 1989; 55: 551-6.
25. Chou TH, Chen SC, Chu IM. Effect of composition on the stability of liposomal irinotecan prepared by a pH gradient method. J Biosci Bioeng 2003; 95: 405-8.
26. Wolkers WF, Oldenhof H, Tablin F et al. Preservation of dried liposomes in the presence of sugar an phosphate. Biochim Biophys Acta 2004; 1661: 125-34.
27. Han M, Watarai S, Kobayashi K et al. Application of liposomes for development of oral vaccines: Study in vitro stability of liposomes and antibody response to antigen assoc with liposomes after oral immunization. J Vet Med Sci 1997; 59: 1109-14.
28. Sachetelli S, Beaulac C La J Aminoglycoside detection using a universal ELISA binding procedure onto polystyrene microtiter, plates in comparison with HPLC analysis and microbiological agar-diffusion assay. Biochim Biophys Acta 1998; 1379: 35-41.
29. Aronoff SC. Outer membrane permeability in Pseudomonas cepacia. diminished porin content in a β-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents Chemother 1988; 32: 1636-9.
30. Burns JL, Hedin LA, Lien DM. Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability. Antimicrob Agents Chemother 1989; 33: 136-41.
31. Burns JL, Clark DK. Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother 1992; 36: 2280-5.
32. Mugabe C, Halwani M, Azghani AO et al. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseucomonas aeruginosa. Antimicrob Agents Chemother 2006; 50 2016-22.
33. Kotra LP, Haddad J, Mobashery P. Aminoglycosides: Perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother 2000; 44: 3249-56.
34. Cordeiro C, Wiseman DJ, Lutwyche P et al. Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar Typhimurium intracellular infection model. Antimicrob Agents Chemother 2000; 44: 533-9:
35. Horan PK, Slezak SE. Stable cell membrane labelling. Nature 1989 340: 167-8.
36. Kempf VA, Bohn E, Noll A et al. In vivo tracking and protective properties of Yersinia-specific intestinal T cells. Clin Exp Immunol 1998; 113: 429-37.
37. Kumar N, Blumenthal R, Henkart M et al. Aggregation and calcium-induced fusion of phosphatidylcholine vesicle-tubulin complexes. J Biol Chem 1982; 257: 15137-44
38. Nichols JW, Pagano RE. Resonance energy transfer assay of protein-mediated lipid transfer between vesicles J Biol Chem 1983; 258: 5368-71.